The study suggests a new possible framework for treating people with familial hypercholesterolemia, an inherited condition characterized by extremely high levels of LDL, the so-called “bad cholesterol.”
UCLA researchers’ study using zebrafish shows how the disease turns a repair mechanism into one that damages nerve cells. The findings could lead to treatments to prevent nerve damage in leprosy and other diseases.
The finding represents one of the clearest examples to date of the phenomenon — stretches of DNA that exist for no reason other than promoting their own inheritance — at the molecular level.
CancerLocator, developed by UCLA researchers, was superior in detecting cancer in blood samples containing low levels of target DNA, which reflect early-stage disease.
Adenosine deaminase-deficient severe combined immunodeficiency is a rare and life-threatening condition that can be fatal within the first year of life if left untreated.
The researchers identified genes that they believe control hundreds of other genes linked to Alzheimer’s disease, Parkinson’s disease, depression and several other disorders.
UCLA School of Nursing researchers found that people with a certain genetic variation who took donepezil for the condition had a faster cognitive decline than those who took a placebo.
The device, developed by UCLA’s Aydogan Ozcan and colleagues in Sweden, could be manufactured for less than $500 each — far less expensive than the equipment that labs use for the same tests.
Neuroscientists at UCLA have developed a new technique for studying a particular type of cell in the brain known as an astrocyte that may play a role in diseases such as Lou Gehrig’s disease and Alzheimer's disease.
A UCLA study used 3D chromosome-mapping technology to advance understanding of disorder’s cause. The work provides important new information about how schizophrenia originates and could lead to better treatments.
In a first-of-its-kind study, UCLA-led researchers have discovered a gene variant that could be a factor in determining which women experience the symptom.
A team of scientists including researchers from UCLA has developed an RNA sequencing technique that could advance scientists’ use of stem cells in regenerative medicine.